TipRanks
Zoetis (IT:1ZTS)
:1ZTS
Italy Market
1ZTS
Zoetis
RESEARCH TOOLSreports

Zoetis (1ZTS) Stock Forecast & Price Target

3 Followers
See the Price Targets and Ratings of:

1ZTS Analyst Ratings

Moderate Buy
12Ratings
Moderate Buy
4 Buy
8 Hold
0 Sell
Based on 12 analysts giving stock ratings to
Zoetis
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

1ZTS Stock 12 Month Forecast

Average Price Target

€78.77
▲(19.82% Upside)
Based on 12 Wall Street analysts offering 12 month price targets for Zoetis in the last 3 months. The average price target is €78.77 with a high forecast of €102.68 and a low forecast of €66.07. The average price target represents a 19.82% change from the last price of €65.74.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"60":"€60","91":"€91","122":"€122","75.5":"€75.5","106.5":"€106.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":102.67774655,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€102.68</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":78.76920846444445,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€78.77</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":66.07089778,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€66.07</span>\n  </div></div>","useHTML":true}}],"tickPositions":[60,75.5,91,106.5,122],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,61.756,64.9038266576923,68.05165331538461,71.19947997307692,74.34730663076922,77.49513328846153,80.64295994615384,83.79078660384616,86.93861326153845,90.08643991923077,93.23426657692306,96.38209323461538,99.52991989230769,{"y":102.67774655,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,61.756,63.0647083434188,64.3734166868376,65.68212503025642,66.99083337367522,68.29954171709402,69.60825006051282,70.91695840393163,72.22566674735043,73.53437509076923,74.84308343418803,76.15179177760685,77.46050012102565,{"y":78.76920846444445,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,61.756,62.08791521384615,62.419830427692304,62.75174564153846,63.083660855384615,63.41557606923077,63.74749128307692,64.07940649692307,64.41132171076923,64.74323692461539,65.07515213846153,65.40706735230769,65.73898256615384,{"y":66.07089778,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":121.751,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":121.96,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":108.484,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":105.179,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":103.288,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":107.687,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":99.537,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":96.405,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.513,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":64.014,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":65.887,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":66.046,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":61.756,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€102.68Average Price Target€78.77Lowest Price Target€66.07
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on IT:1ZTS
Erin Wright
Morgan Stanley
Morgan Stanley
€75.89→€73.21
Buy
11.37%
Upside
Assigned
10/30/26
Zoetis price target lowered to $82 from $85 at Morgan StanleyZoetis price target lowered to $82 from $85 at Morgan Stanley
UBS Analyst forecast on IT:1ZTS
Andrea Alfonso
UBS
UBS
€71.43→€75.89
Hold
15.44%
Upside
Assigned
10/27/26
Zoetis price target raised to $85 from $80 at UBSZoetis price target raised to $85 from $80 at UBS
Jefferies Analyst forecast on IT:1ZTS
Keith Devas
Jefferies
Jefferies
€91.96→€74.11
Hold
12.73%
Upside
Downgraded
10/20/26
Zoetis downgraded to Hold from Buy at JefferiesZoetis downgraded to Hold from Buy at Jefferies
Goldman Sachs Analyst forecast on IT:1ZTS
Matthew Dellatorre
Goldman Sachs
Goldman Sachs
€66.07
Hold
0.50%
Upside
Initiated
10/16/26
Zoetis initiated with a Neutral at Goldman SachsZoetis initiated with a Neutral at Goldman Sachs
J.P. Morgan Analyst forecast on IT:1ZTS
Chris Schott
J.P. Morgan
J.P. Morgan
€102.68
Buy
56.19%
Upside
Reiterated
10/16/26
Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH), Phibro Animal Health (NASDAQ: PAHC) and Zoetis (NYSE: ZTS)
Leerink Partners Analyst forecast on IT:1ZTS
Daniel Clark
Leerink Partners
Leerink Partners
―
Hold
―
Reiterated
10/01/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Zoetis (NYSE: ZTS), Eli Lilly & Co (NYSE: LLY) and Liquidia Technologies (NASDAQ: LQDA)
Stifel Nicolaus Analyst forecast on IT:1ZTS
Jonathan Block
Stifel Nicolaus
Stifel Nicolaus
―
Hold
―
Reiterated
09/18/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Zoetis (NYSE: ZTS), Dexcom (NASDAQ: DXCM) and Alnylam Pharma (NASDAQ: ALNY)
TD Cowen Analyst forecast on IT:1ZTS
Steve Scala
TD Cowen
TD Cowen
€92.86→€83.93
Buy
27.67%
Upside
Assigned
08/25/26
TD Cowen Sticks to Their Buy Rating for Zoetis (ZTS)
Barclays Analyst forecast on IT:1ZTS
Glen Santangelo
Barclays
Barclays
€75.89
Hold
15.44%
Upside
Reiterated
08/17/26
Barclays Keeps Their Hold Rating on Zoetis (ZTS)
Citi Analyst forecast on IT:1ZTS
Daniel Grosslight
Citi
Citi
€100→€85.71
Buy
30.38%
Upside
Reiterated
08/11/26
Zoetis price target lowered to $96 from $112 at CitiZoetis price target lowered to $96 from $112 at Citi
Piper Sandler Analyst forecast on IT:1ZTS
David Westenberg
Piper Sandler
Piper Sandler
€80.36→€71.43
Hold
8.65%
Upside
Reiterated
08/10/26
Zoetis price target lowered to $80 from $90 at Piper SandlerZoetis price target lowered to $80 from $90 at Piper Sandler
William Blair Analyst forecast on IT:1ZTS
Brandon Vazquez
William Blair
William Blair
―
Hold
―
Downgraded
08/08/26
Analysts Offer Insights on Healthcare Companies: Ligand Pharma (NASDAQ: LGND), Protagonist Therapeutics (NASDAQ: PTGX) and Zoetis (NYSE: ZTS)
Bank of America Securities Analyst forecast on IT:1ZTS
Michael Ryskin
Bank of America Securities
Bank of America Securities
―
Hold
―
Reiterated
07/28/26
Analysts Conflicted on These Healthcare Names: BioMarin Pharmaceutical (NASDAQ: BMRN), Zoetis (NYSE: ZTS) and Vertex Pharmaceuticals (NASDAQ: VRTX)
HSBC Analyst forecast on IT:1ZTS
Sidharth Sahoo
HSBC
HSBC
€125→€84.82
Buy
29.02%
Upside
Reiterated
07/06/26
Zoetis price target lowered to $95 from $140 at HSBCZoetis price target lowered to $95 from $140 at HSBC
Argus Research Analyst forecast on IT:1ZTS
Jasper Hellweg
Argus Research
Argus Research
―
Hold
―
Downgraded
05/26/26
Zoetis downgraded to Hold from Buy at ArgusZoetis downgraded to Hold from Buy at Argus
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Morgan Stanley Analyst forecast on IT:1ZTS
Erin Wright
Morgan Stanley
Morgan Stanley
€75.89→€73.21
Buy
11.37%
Upside
Assigned
10/30/26
Zoetis price target lowered to $82 from $85 at Morgan StanleyZoetis price target lowered to $82 from $85 at Morgan Stanley
UBS Analyst forecast on IT:1ZTS
Andrea Alfonso
UBS
UBS
€71.43→€75.89
Hold
15.44%
Upside
Assigned
10/27/26
Zoetis price target raised to $85 from $80 at UBSZoetis price target raised to $85 from $80 at UBS
Jefferies Analyst forecast on IT:1ZTS
Keith Devas
Jefferies
Jefferies
€91.96→€74.11
Hold
12.73%
Upside
Downgraded
10/20/26
Zoetis downgraded to Hold from Buy at JefferiesZoetis downgraded to Hold from Buy at Jefferies
Goldman Sachs Analyst forecast on IT:1ZTS
Matthew Dellatorre
Goldman Sachs
Goldman Sachs
€66.07
Hold
0.50%
Upside
Initiated
10/16/26
Zoetis initiated with a Neutral at Goldman SachsZoetis initiated with a Neutral at Goldman Sachs
J.P. Morgan Analyst forecast on IT:1ZTS
Chris Schott
J.P. Morgan
J.P. Morgan
€102.68
Buy
56.19%
Upside
Reiterated
10/16/26
Analysts Offer Insights on Healthcare Companies: Cardinal Health (NYSE: CAH), Phibro Animal Health (NASDAQ: PAHC) and Zoetis (NYSE: ZTS)
Leerink Partners Analyst forecast on IT:1ZTS
Daniel Clark
Leerink Partners
Leerink Partners
―
Hold
―
Reiterated
10/01/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Zoetis (NYSE: ZTS), Eli Lilly & Co (NYSE: LLY) and Liquidia Technologies (NASDAQ: LQDA)
Stifel Nicolaus Analyst forecast on IT:1ZTS
Jonathan Block
Stifel Nicolaus
Stifel Nicolaus
―
Hold
―
Reiterated
09/18/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Zoetis (NYSE: ZTS), Dexcom (NASDAQ: DXCM) and Alnylam Pharma (NASDAQ: ALNY)
TD Cowen Analyst forecast on IT:1ZTS
Steve Scala
TD Cowen
TD Cowen
€92.86→€83.93
Buy
27.67%
Upside
Assigned
08/25/26
TD Cowen Sticks to Their Buy Rating for Zoetis (ZTS)
Barclays Analyst forecast on IT:1ZTS
Glen Santangelo
Barclays
Barclays
€75.89
Hold
15.44%
Upside
Reiterated
08/17/26
Barclays Keeps Their Hold Rating on Zoetis (ZTS)
Citi Analyst forecast on IT:1ZTS
Daniel Grosslight
Citi
Citi
€100→€85.71
Buy
30.38%
Upside
Reiterated
08/11/26
Zoetis price target lowered to $96 from $112 at CitiZoetis price target lowered to $96 from $112 at Citi
Piper Sandler Analyst forecast on IT:1ZTS
David Westenberg
Piper Sandler
Piper Sandler
€80.36→€71.43
Hold
8.65%
Upside
Reiterated
08/10/26
Zoetis price target lowered to $80 from $90 at Piper SandlerZoetis price target lowered to $80 from $90 at Piper Sandler
William Blair Analyst forecast on IT:1ZTS
Brandon Vazquez
William Blair
William Blair
―
Hold
―
Downgraded
08/08/26
Analysts Offer Insights on Healthcare Companies: Ligand Pharma (NASDAQ: LGND), Protagonist Therapeutics (NASDAQ: PTGX) and Zoetis (NYSE: ZTS)
Bank of America Securities Analyst forecast on IT:1ZTS
Michael Ryskin
Bank of America Securities
Bank of America Securities
―
Hold
―
Reiterated
07/28/26
Analysts Conflicted on These Healthcare Names: BioMarin Pharmaceutical (NASDAQ: BMRN), Zoetis (NYSE: ZTS) and Vertex Pharmaceuticals (NASDAQ: VRTX)
HSBC Analyst forecast on IT:1ZTS
Sidharth Sahoo
HSBC
HSBC
€125→€84.82
Buy
29.02%
Upside
Reiterated
07/06/26
Zoetis price target lowered to $95 from $140 at HSBCZoetis price target lowered to $95 from $140 at HSBC
Argus Research Analyst forecast on IT:1ZTS
Jasper Hellweg
Argus Research
Argus Research
―
Hold
―
Downgraded
05/26/26
Zoetis downgraded to Hold from Buy at ArgusZoetis downgraded to Hold from Buy at Argus
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ARDXArdelyx
PVLAPalvella Therapeutics
CELCCelcuity
AMRXAmneal Pharmaceuticals
DNTHDianthus Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Zoetis

3 Months
Erin WrightMorgan Stanley
Success Rate
14/24 ratings generated profit
58%
Average Return
+1.74%
Copying Erin Wright's trades and holding each position for 3 Months would result in 58.33% of your transactions generating a profit, with an average return of +1.74% per trade.
1 Year
Steve ScalaTD Cowen
Success Rate
11/20 ratings generated profit
55%
Average Return
-0.32%
Copying Steve Scala's trades and holding each position for 1 Year would result in 55.00% of your transactions generating a profit, with an average return of -0.32% per trade.
2 Years
Steve ScalaTD Cowen
Success Rate
11/20 ratings generated profit
55%
Average Return
+6.78%
Copying Steve Scala's trades and holding each position for 2 Years would result in 55.00% of your transactions generating a profit, with an average return of +6.78% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1ZTS Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
3
3
1
1
1
Buy
6
6
7
5
5
Hold
11
12
13
11
11
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
20
21
21
17
17
In the current month, 1ZTS has received 6 Buy Ratings, 11 Hold Ratings, and 0 Sell Ratings. 1ZTS average Analyst price target in the past 3 months is 78.77.
Each month's total comprises the sum of three months' worth of ratings.

1ZTS Financial Forecast

1ZTS Earnings Forecast

Next quarter’s earnings estimate for 1ZTS is €1.35 with a range of €1.29 to €1.44. The previous quarter’s EPS was €1.67. 1ZTS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 1ZTS has Performed in-line its overall industry.
Next quarter’s earnings estimate for 1ZTS is €1.35 with a range of €1.29 to €1.44. The previous quarter’s EPS was €1.67. 1ZTS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 1ZTS has Performed in-line its overall industry.

1ZTS Sales Forecast

Next quarter’s sales forecast for 1ZTS is €2.06B with a range of €2.02B to €2.09B. The previous quarter’s sales results were €2.20B. 1ZTS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 1ZTS has Performed in-line its overall industry.
Next quarter’s sales forecast for 1ZTS is €2.06B with a range of €2.02B to €2.09B. The previous quarter’s sales results were €2.20B. 1ZTS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 1ZTS has Performed in-line its overall industry.

1ZTS Stock Forecast FAQ

What is IT:1ZTS’s average 12-month price target, according to analysts?
Based on analyst ratings, Zoetis’s 12-month average price target is 78.77.
    What is IT:1ZTS’s upside potential, based on the analysts’ average price target?
    Zoetis has 19.82% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Zoetis a Buy, Sell or Hold?
          Zoetis has a consensus rating of Moderate Buy, which is based on 4 buy ratings, 8 hold ratings and 0 sell ratings.
            What is Zoetis’s share price target?
            The average share price target for Zoetis is 78.77. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €102.68 ,and the lowest forecast is €66.07. The average share price target represents 19.82% Increase from the current price of €65.74.
              What do analysts say about Zoetis?
              Zoetis’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 12 Wall Streets Analysts.
                How can I buy shares of Zoetis?
                To buy shares of IT:1ZTS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.